Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 18 Neoplasm Metastasis 6 Urogenital Neoplasms 1 Unilateral Breast Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Locally Advanced (Inoperable) or Metastatic Breast Cancer 1 HR+/HER2- Breast Cancer 1 Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1 Carcinoma, Non-Small-Cell Lung 1 Breast Diseases 1 Breast Cancer Female 1 Advanced Breast Cancer 1

Interventions

Tamoxifen 2 pegfilgrastim 1 exemestane 1 abemaciclib 1 Tretinoin 1 Tocopherols 1 Standard of Care 1 Mifepristone 1 Letrozole 1 Isotretinoin 1 Dexmedetomidine 1 Cannabidiol 1 Bupivacaine 1 Anastrozole 1 Alitretinoin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Breast Cancer Female × abemaciclib × Clear all

NCT04584853 2026-01-14

POETIC-A

Institute of Cancer Research, United Kingdom

Phase 3 Active not recruiting

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡